Invesco Ltd. Aurinia Pharmaceuticals Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Invesco Ltd. holds 142,691 shares of AUPH stock, worth $1.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

142,691

Previous 143,668 0.68%

Holding current value

$1.26 Million

Previous $820,000 27.44%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$5.32 - $7.33 $5,197 - $7,161	-977 Reduced 0.68%	142,691 $1.05 Million
Q2 2024 Aug 13, 2024	BUY	$4.81 - $5.78 $12,568 - $15,103	2,613 Added 1.85%	143,668 $820,000
Q1 2024 May 14, 2024	SELL	$4.93 - $9.31 $17,915 - $33,832	-3,634 Reduced 2.51%	141,055 $706,000
Q4 2023 Feb 12, 2024	BUY	$7.13 - $9.49 $69,524 - $92,536	9,751 Added 7.23%	144,689 $1.3 Million
Q3 2023 Nov 13, 2023	BUY	$7.77 - $12.27 $66,130 - $104,429	8,511 Added 6.73%	134,938 $1.05 Million
Q2 2023 Aug 11, 2023	SELL	$8.96 - $11.69 $2,544 - $3,319	-284 Reduced 0.22%	126,427 $1.22 Million
Q1 2023 May 12, 2023	BUY	$5.94 - $11.27 $262,120 - $497,322	44,128 Added 53.43%	126,711 $1.39 Million
Q4 2022 Feb 13, 2023	SELL	$4.11 - $8.14 $24,117 - $47,765	-5,868 Reduced 6.63%	82,583 $356,000
Q3 2022 Nov 14, 2022	BUY	$6.66 - $12.39 $13,220 - $24,594	1,985 Added 2.3%	88,451 $665,000
Q2 2022 Aug 15, 2022	BUY	$8.95 - $12.8 $480,749 - $687,552	53,715 Added 164.01%	86,466 $868,000
Q1 2022 May 16, 2022	BUY	$10.05 - $22.48 $214,467 - $479,723	21,340 Added 187.01%	32,751 $405,000
Q4 2021 Feb 14, 2022	SELL	$17.78 - $33.08 $57,216 - $106,451	-3,218 Reduced 22.0%	11,411 $261,000
Q3 2021 Nov 15, 2021	SELL	$10.93 - $23.55 $36,528 - $78,704	-3,342 Reduced 18.6%	14,629 $324,000
Q2 2021 Aug 17, 2021	BUY	$10.0 - $14.52 $179,710 - $260,938	17,971 New	17,971 $233,000

Others Institutions Holding AUPH

# of Institutions

208

Shares Held

58.6M

Call Options Held

1.14M

Put Options Held

1.51M

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.26B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account